Share:
Breakthrough technology evaluates cognitive function when a brain disorder such as injury, dementia or neurological impacts of COVID-19 are suspected
VoxNeuro announces the release of their software as a medical device, the Cognitive Health Assessment Management Platform™ (CHAMP), as they pave their way to the US market. With successful registration with the FDA as a Medical Device Establishment for the distribution of the CHAMP software, a Class II Exempt Medical Device, VoxNeuro is on plan to globally change the way brain health is managed and treated.
CHAMP works in tandem with VoxNeuro s Cognitive Health Assessment
TM to proactively track cognitive health throughout aging, and to evaluate cognitive function when a brain disorder or symptoms related to cognitive dysfunction are suspected.
Neuroscience and Novel Therapeutics Unit: Meet the Team
The Neuroscience and Novel Therapeutics Unit (NNT) is a group of dedicated, compassionate, and talented scientists, clinicians, trainees, and volunteers. Our expert, interdisciplinary team works together to study and develop new treatments for children with psychiatric illnesses through innovative research, clinical care, and community outreach.
Staff Spotlight
Simone Haller, PhD has received a two-year NARSAD Young Investigator Grant from the Brain and Behavior Research Foundation for her project “Predicting longitudinal psychiatric effects of the COVID-19 pandemic in a transdiagnostic sample of youth using rest and task-based fMRI.”
Melissa A. Brotman, PhD was awarded a second NIH Bench to Bedside Award for her proposal, in collaboration with the University of Wisconsin s Dr. Ned Kalin, entitled “Cross-Species Circuit-Based Treatment: White Matter Microstructure in Anxiety.” In 2017, a study by Drs. Brotman and Kal
Intoxicating effects of alcohol linked with brain regions, finds study ANI | Updated: Apr 18, 2021 14:01 IST
Baltimore (Maryland) [US], April 18 (ANI): A recent study has pointed out that slurred speech, poor coordination, and sedative effects of drinking too much alcohol may actually be caused by the breakdown of alcohol products produced in the brain and not the liver as scientists currently think.
That is the finding of a new study led by researchers from the University of Maryland School of Medicine (UMSOM) and the National Institute on Alcohol Abuse and Alcoholism. It was published recently in the journal Nature Metabolism and provides new insights into how alcohol may affect the brain and the potential for new treatments to treat alcohol misuse.
Researchers find brain regions responsible for intoxicating effects of alcohol ANI | Updated: Apr 17, 2021 08:23 IST
Baltimore (Maryland) [US], April 17 (ANI): The slurred speech, poor coordination, and sedative effects of drinking too much alcohol may actually be caused by the breakdown of alcohol products produced in the brain, not in the liver as scientists currently think.
That is the finding of a new study led by researchers from the University of Maryland School of Medicine (UMSOM) and the National Institute on Alcohol Abuse and Alcoholism. It was published recently in the journal Nature Metabolism and provides new insights into how alcohol may affect the brain and the potential for new treatments to treat alcohol misuse.
‘Radiologist of the Millennium’ Dr Kakarla Subba Rao leaves a legacy behind
By M Somasekhar| Updated: 16th April 2021 3:38 pm IST
It was locally known as the ‘Bokkala Dhawakhana’ or the hospital for bones in the 1970’s. By the turn of the century it emerged as one of the top super specialty hospitals in the country. The transition Nizam’s Orthopedic hospital into the Nizam’s Institute of Medical Sciences(NIMS) is an exemplary story.
Playing a significant part in shaping this makeover was Dr Kakarla Subba Rao, a noted Radiologist. He oversaw the change, growth and diversification in the mid 1980s with a tough, no-nonsense and committed attitude. Today, the NIMS is a huge facility with expertise and research capabilities in almost all disciplines of modern healthcare.